Concepedia

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era

Christopher P. Fox, David Burns, Anne Parker, Karl S. Peggs, Caroline M. Harvey, Shiva Natarajan, D I Marks, Bridget Jackson, Geothy Chakupurakal, Michael Dennis,

Bone Marrow Transplantation · 2013 · 89 citations · 24 references

DOI

Concepts

References

24

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

Esperanza B. Papadopoulos, Marc Ladanyi, David Emanuel et al. · New England Journal of Medicine · 1994 · 1.1K citations · Full text

, , +12

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

Helen E. Heslop, Karen S. Slobod, Martin Pulé et al. · Blood · 2009 · 778 citations · Full text

, , +17

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Panagiotis Kottaridis, Donald Milligan, Rajesh Chopra et al. · Blood · 2000 · 502 citations

, , +14

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

Ekaterina Doubrovina, Banu Oflaz-Sozmen, Susan E. Prockop et al. · Blood · 2011 · 421 citations · Full text

, , +15

Epstein-Barr virus lymphoproliferation after bone marrow transplantation

MM Zutter, PJ Martin, GE Sale et al. · Blood · 1988 · 412 citations · Full text

, , +13